87S:FRA
Roivant Sciences Ltd
€29.67
0.00%
(0.00) 1D
Oct 19, 3:25:02 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 87S...
Open
€29.60
High
€29.67
Low
€29.60
Mkt. cap
25.08B
Avg. vol.
25.00
Volume
0.00
52-wk high
€35.82
52-wk low
€14.34
No. of employees
721
Open
€29.60
High
€29.67
Low
€29.60
Mkt. cap
25.08B
Avg. vol.
25.00
Volume
0.00
52-wk high
€35.82
52-wk low
€14.34
No. of employees
721
News stories
From web sources and news partners
TradingView
·
29 minutes ago
Midday Pulse: S&P 500 top intraday losers
bloomingbit
·
1 hour ago
U.S. Stocks Turn Higher; Nasdaq Up 1.36%
Investor's Business Daily
·
31 minutes ago
Magnificent Seven Are Losing Their Earnings Luster
24/7 Wall St.
·
2 hours ago
S&P 500 Climbs to 7,721 at Midday, Led by a Tech-Heavy Surge
Profile
Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel. Wikipedia
About Roivant Sciences Ltd